Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by MOOS WALTER H, Director. Insider active across 2 companies, notably Rigel Pharmaceuticals INC. Aggregated, 5 disclosures have been published. History available since 19 May 2021. The latest transaction was filed on 25 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Walter H. Moos is a Board Member at Rigel Pharmaceuticals Inc. He brings valuable expertise in the pharmaceutical sector, contributing to strategic decision-making for the company. His role includes overseeing operations and evaluating performance, ensuring that the company's objectives are met.